Nature Communications (Jun 2022)
Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity
Abstract
Inducing ferroptosis of tumour cells is a promising therapeutic approach in cancer. Authors show here that on the other hand, cells dying via ferroptosis are less immunogenic than necroptotic cells, they inhibit maturation and antigen cross-presentation of dendritic cells, hence lessen the anti-tumour immune response.